0001062993-16-011355.txt : 20160830
0001062993-16-011355.hdr.sgml : 20160830
20160830191708
ACCESSION NUMBER: 0001062993-16-011355
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160829
FILED AS OF DATE: 20160830
DATE AS OF CHANGE: 20160830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wegman Toby
CENTRAL INDEX KEY: 0001405128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 161861677
MAIL ADDRESS:
STREET 1: 4092 BOCAIRE BLVD.
CITY: BOCA RATON
STATE: FL
ZIP: 33487
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2016-08-29
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001405128
Wegman Toby
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
1
1
0
President
Common Stock, $.001 par value
2016-08-29
4
S
0
1607
37.6107
D
978571
I
See footnote
Common Stock, $.001 par value
2016-08-30
4
S
0
2692
37.5027
D
975879
I
See footnote
The selling price of $37.6107 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $37.51 to $37.625. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The selling price of $37.5027 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $37.5005 to $37.61. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares are held in trust on behalf of the reporting person and Mr. Thomas Wegman. The reporting person is the co-trustee of the trust with Mr. Thomas Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.
/s/ Carl A. Valenstein, attorney-in-fact for Toby Wegman
2016-08-30